1-9 of 9
Georgine E. de Greef
Close
Sort by
Journal Articles

Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML

Clinical Trials & Observations
Bob Löwenberg, Thomas Pabst, Johan Maertens, Yvette van Norden, Bart J. Biemond, Harry C. Schouten, Olivier Spertini, Edo Vellenga, Carlos Graux, Violaine Havelange, Georgine E. de Greef, Okke de Weerdt, Marie-Cecile J. C. Legdeur, Juergen Kuball, Marinus van Marwijk Kooy, Bjorn T. Gjertsen, Mojca Jongen-Lavrencic, Arjan A. van de Loosdrecht, Daniëlle van Lammeren-Venema, Beata Hodossy, Dimitri A. Breems, Yves Chalandon, Jakob Passweg, Peter J. M. Valk, Markus G. Manz, Gert J. Ossenkoppele
Journal: Blood
Blood (2017) 129 (12): 1636–1645.
https://doi.org/10.1182/blood-2016-10-740613
Published: 2017
Includes: Supplemental data
Journal Articles

Trends in Incidence, Primary Treatment and Survival of Chronic Myelomonocytic Leukemia: A Nationwide Population-Based Study Among 1,359 Patients Diagnosed in the Netherlands from 1989 to 2012

Avinash G Dinmohamed, MSc, BASc, Mirian Brink, PhD, Otto Visser, MD PhD, Pieter Sonneveld, MDPhD, Arjan A van de Loosdrecht, MD PhD, Mojca Jongen-Lavrencic, MD PhD, Georgine E. de Greef, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4645.
https://doi.org/10.1182/blood.V124.21.4645.4645
Published: 2014
Journal Articles

Erythroid Lineage Analysis By Flow Cytometry Is of Highly Additive Value for MDS Diagnosis: A Study on Behalf of the HOVON89 Study Group

Eline MP Cremers, MD, Theresia M Westers, PhD, Canan Alhan, MD, Claudia Cali, Heleen A Visser-Wisselaar, PhD, Dana A Chitu, PhD, Marian JPL Stevens-Kroef, PhD, Pedro Silva Coelho, MD, Edo Vellenga, MDPhD, Saskia K. Klein, MDPhD, Pierre W. Wijermans, MDPhD, Georgine E De Greef, Marie-Cecile Legdeur, MD PhD, Petra Muus, MD PhD, Gert J Ossenkoppele, MD PhD, Joop H Jansen, PhD, Arjan A Van de Loosdrecht, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4667.
https://doi.org/10.1182/blood.V124.21.4667.4667
Published: 2014
Journal Articles

Lymphocyte and Hematopoietic Stem and Progenitor Cell (HSPC) Subsets Mobilized By Either Plerixafor or G-GCSF: A Retrospective Comparison of Grafts Harvested in Healthy Allogeneic Stem Cell Donors

Georgine E. De Greef, MD PhD, Eric Braakman, PhD, Wendimagegn G Alemayehu, PhD, Larissa De Graaf, Peter van Geel, Meriam Grootes, Carla Engelman, Eefke Petersen, MDPhD, Otto Visser, MDhD, Vladan Vucinic, MD, Dietger Niederwieser, MD, Jan J. Cornelissen, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2451.
https://doi.org/10.1182/blood.V124.21.2451.2451
Published: 2014
Journal Articles

Validation Of a Multi-Diagnostic Approach Including Flow Cytometry To Identify Specific Risk Categories Within Low and Intermediate-1 Risk Myelodysplastic Syndromes Within a Prospective Clinical Trial: A Study On Behalf Of The HOVON89 Study Group

Eline M.P. Cremers, MD, Theresia M. Westers, PhD, Canan Alhan, MD, Claudia Cali, Heleen A. Visser-Wisselaar, PhD, Dana A Chitu, PhD, Marian J.P.L. Stevens-Kroef, PhD, Pedro Silva Coelho, MD, Edo Vellenga, MD, PhD, Saskia K. Klein, MD PhD, Pierre W. Wijermans, MD, PhD, Georgine E. de Greef, MD, PhD, Martijn R. Schaafsma, MD, PhD, M Marwijk Kooy, MD, PhD, Petra Muus, MD, PhD, Gert J. Ossenkoppele, MD PhD, Joop H. Jansen, PhD, Arjan A. van de Loosdrecht, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1521.
https://doi.org/10.1182/blood.V122.21.1521.1521
Published: 2013
Journal Articles

Identification Of Chromosomal Abnormalities By Microarray-Based Genomic Profiling As Compared To Karyotyping In Patients With Low and Intermediate-1 Risk Myelodysplastic Syndromes Within a Prospective Clinical Trial: A Study On Behalf Of The HOVON89 Study Group

Marian J.P.L. Stevens-Kroef, PhD, Annet Simons, Najat El Idrissi-Zaynoun, Bert A. van der Reijden, Eline M.P. Cremers, MD, Canan Alhan, Theresia M. Westers, Heleen A. Visser-Wisselaar, PhD, Dana Chitu, Edo Vellenga, S. K. Klein, Pierre W. Wijermans, MD, Georgine E. De Greef, Martyn R. Schaafsma, M. van Marwijk Kooy, Petra Muus, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht, Joop H. Jansen, PhD
Journal: Blood
Blood (2013) 122 (21): 1338.
https://doi.org/10.1182/blood.V122.21.1338.1338
Published: 2013
Journal Articles

Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK)

Clinical Trials & Observations
Gert J. Ossenkoppele, Georg Stussi, Johan Maertens, Kees van Montfort, Bart J. Biemond, Dimitri Breems, August Ferrant, Carlos Graux, Georgine E. de Greef, C. J. M. Halkes, Mels Hoogendoorn, Rene M. Hollestein, Mojca Jongen-Lavrencic, Mark D. Levin, Arjan A. van de Loosdrecht, Marinus van Marwijk Kooij, Yvette van Norden, Thomas Pabst, Harry C. Schouten, Edo Vellenga, Gregor E. G. Verhoef, Okke de Weerdt, Pierre Wijermans, Jakob R. Passweg, Bob Löwenberg
Journal: Blood
Blood (2012) 120 (24): 4706–4711.
https://doi.org/10.1182/blood-2012-04-420596
Published: 2012
Includes: Supplemental data
Journal Articles

The Mobilisation of Peripheral Blood Stemcells in Patients with High Risk or Relapsed Non-Hodgkin Lymphoma Does Not Lead to the Presence of Detectable Tumour Cells in the Stem Cell Harvest.

Georgine E. de Greef, MD PhD, Annemiek Broyl, MD, Jaco Kraan
Journal: Blood
Blood (2004) 104 (11): 2873.
https://doi.org/10.1182/blood.V104.11.2873.2873
Published: 2004
Journal Articles

High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients

Clinical Trials & Observations
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Claudia Erpelinck, Wim L. J. van Putten, Peter J. M. Valk, Sonja van der Poel-van de Luytgaarde, Ronald Hack, Rosalyn Slater, Elisabeth M. E. Smit, H. Berna Beverloo, Gregor Verhoef, Leo F. Verdonck, Gert J. Ossenkoppele, Pieter Sonneveld, Georgine E. de Greef, Bob Löwenberg, Ruud Delwel
Journal: Blood
Blood (2003) 101 (3): 837–845.
https://doi.org/10.1182/blood-2002-05-1459
Published: 2003